论文部分内容阅读
目的探讨痰热清对COPD急性加重期合并肺部感染的临床疗效。方法将80例COPD急性加重期合并肺部感染的患者随机分为痰热清组和对照组。对照组给予常规西医治疗方法;痰热清组在西医常规治疗基础上加用痰热清20 ml,加入5%葡萄糖注射液250 ml内静脉滴注,1次/d。两组均以10 d为一个疗程。结果痰热清组总有效率92.50%,对照组有效率85.00%(P<0.05)。结论痰热清治疗COPD急性加重期合并肺部感染疗效明显提高,用药安全,值得进一步研究推广。
Objective To investigate the clinical efficacy of Tanreqing on COPD patients with acute pulmonary infection. Methods Eighty patients with acute exacerbation of COPD and pulmonary infection were randomly divided into Tanreqing group and control group. The control group was given routine Western medical treatment; Tanreqing group was added with Tanreqing 20 ml on the basis of routine treatment of Western medicine, and intravenous drip of 250 ml 5% dextrose injection once per day. Both groups were 10 days for a course of treatment. Results The total effective rate was 92.50% in Tanreqing group and 85.00% in control group (P <0.05). Conclusion Tanreqing treatment of acute exacerbation of COPD with pulmonary infection significantly improved the efficacy of drug safety, it is worth further study and promotion.